Clicky

 

Intelligence » Arthritis » Last Week

Subscribe to get latest posts via email or subscribe to a RSS feed.

Flexion Therapeutics to acquire novel and non-opioid asset for osteoarthritis of knee

Thursday, December 14, 2017 -- Flexion Therapeutics has entered into a definitive agreement with GeneQuine Biotherapeutics GmbH to acquire the global rights to GQ-203.

Immunotherapy Drug for Rheumatoid Arthritis Nearly Eliminates Severe Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplant

Saturday, December 09, 2017 -- (MENAFN Editorial) SEATTLE, Dec. 9, 2017 /PRNewswire-USNewswire/ --Results from a phase 2 clinical trial, presented by at the 59th American Society of Hematology (ASH) Annual Meeti...

Ampio Pharmaceuticals Reports Positive Results for both Primary and Secondary Endpoints of Pivotal Phase 3 Trial of Ampion™ in Severe Osteoarthritis-of-the Knee (OAK)

Thursday, December 14, 2017 -- (MENAFN Editorial) ENGLEWOOD, Colo., Dec. 14, 2017 /PRNewswire/ -- (NYSE MKT: AMPE) today reported that the Phase 3 clinical trial of Ampion™ met its primary endpoint with 71% of A...

Knee Osteoarthritis Patients Receive Little Benefit From Bisphosphonates

Wednesday, December 13, 2017 -- Bisphosphonates did not show to be beneficial for patients with knee osteoarthritis.

Cooled Radiofrequency Ablation Effective for Osteoarthritis Knee Pain

Wednesday, December 13, 2017 -- For patients with osteoarthritis-related knee pain, cooled radiofrequency ablation may provide greater pain relief compared with steroid injections.

Short- and Long-Acting Opioids Equally Effective for Osteoarthritis Pain Management

Wednesday, December 13, 2017 -- Short-acting opioids are comparable with long-acting opioid medications for managing pain in patients with chronic osteoarthritis.

CV Risk Scores Underestimate Subclinical Atherosclerosis in Psoriatic Arthritis

Wednesday, December 13, 2017 -- Cardiovascular risk assessment tools in patients with PsA have been shown to underestimate the risk for carotid subclinical atherosclerosis.

Early Treatment of Undifferentiated Arthritis May Delay RA Development

Thursday, December 14, 2017 -- Early treatment of undifferentiated arthritis may delay progression to rheumatoid arthritis.

Assessing Fear, Psychological Distress in Rheumatoid Arthritis and Axial Spondyloarthritis

Monday, December 11, 2017 -- The Fear Assessment in Inflammatory Rheumatic diseases questionnaire may be useful to evaluate the levels of fear and psychological distress in patients with rheumatoid arthritis and axial spondyloarthritis.

Rheumatoid Arthritis Patients Treated With Biologics, Risk of Malignancy

Thursday, December 14, 2017 -- Using biologics to treat rheumatoid arthritis patients does not appear to increase the risk of a second malignancy in individuals with history of cancer.

Ixekizumab Gets FDA Nod for Active Psoriatic Arthritis

Tuesday, December 12, 2017 -- Psoriatic arthritis is the second approved indication for Taltz in the United States.

Colorado biotech's knee osteoarthritis drug gets good results, stock soars

Thursday, December 14, 2017 -- Shares in Ampio Pharmaceuticals Inc. were soaring in early Thursday trading after the Douglas County biotech reported good results from a trial of its knee osteoarthritis drug Ampion. Shares in Ampio (NYSE: AMPE) were up more than 40 percent early Thursday, rising 80 cents to $2.55. Ampio said patients in the trial experienced, on average a 53 percent decrease in pain, a 50 percent improvement in function, and a 45 percent improvement in quality of life. "We are very pleased with the positive…

Amalgam Rx Partners with UCB on BEYOND a Digital Health Solution for Patients with Psoriasis and Psoriatic Arthritis

Wednesday, December 13, 2017 -- WILMINGTON, Del., Dec. 13, 2017 -- Allay Rx, a subsidiary of Amalgam Rx, Inc., a leading digital therapeutics company, announced today a partnership on a comprehensive behavioral and patient support program, BEYOND, for...

Flexion Therapeutics Announces Acquisition of Novel Non-Opioid Asset for Osteoarthritis of the Knee

Wednesday, December 13, 2017 -- Acquisition complements existing portfolio with an innovative, locally administered therapeutic intended to provide persistent effective concentrations of IL-1Ra in the knee for at least a yearNew preclinical program holds...

Arthritis Drug Seen Lowering GvHD Risk (CME/CE)

Tuesday, December 12, 2017 -- (MedPage Today) -- 'Amazing' results in high-risk patients

Children born to women with rheumatoid arthritis have increased risk for chronic diseases

Monday, December 11, 2017 -- New research reveals that children born to women with rheumatoid arthritis face an increased susceptibility for certain chronic diseases. The findings, which appear in Arthritis Care & Research, should be used to increase awareness among pediatricians and general practitioners.